Pharming Group (PHAR) Expected to Announce Earnings on Thursday

Pharming Group (NASDAQ:PHAR) is anticipated to announce its earnings results before the market opens on Thursday, March 13th. Analysts expect the company to announce earnings of $0.07 per share and revenue of $76.67 million for the quarter.

Pharming Group Stock Performance

Pharming Group stock opened at $8.86 on Thursday. Pharming Group has a 12-month low of $6.65 and a 12-month high of $11.94. The company has a quick ratio of 2.76, a current ratio of 3.53 and a debt-to-equity ratio of 0.41. The business’s 50-day moving average price is $9.25 and its two-hundred day moving average price is $8.56. The stock has a market cap of $602.75 million, a PE ratio of -34.08 and a beta of -0.10.

Analyst Ratings Changes

A number of research analysts have issued reports on PHAR shares. HC Wainwright reiterated a “buy” rating and issued a $37.00 target price on shares of Pharming Group in a research report on Tuesday, December 17th. Jefferies Financial Group assumed coverage on Pharming Group in a research note on Monday, December 9th. They set a “buy” rating and a $14.00 price target on the stock.

About Pharming Group

Pharming Group N.V., a biopharmaceutical company, develops and commercializes protein replacement therapies and precision medicines for the treatment of rare diseases in the United States, Europe, and internationally. The company offers RUCONEST, a recombinant C1 esterase inhibitor for the treatment of acute attacks in adult and adolescent patients with acute hereditary angioedema (HAE); and Joenja (leniolisib), an oral small molecule PI3K? inhibitor for the treatment of activated phosphoinositide 3-kinase delta syndrome.